china glp-1 Innovent's weight-loss drug highlights challenge for Novo, Lilly GLP-1 GOSSIP - xoxo ,

Create a plan: If a patient expresses interest in reducing drinking, collaborate on actionable steps, such as setting limits, tracking intake, or engaging support groups

It is important to note that there is no definitive scientific consensus that these drugs directly cause pancreatitis, and the absolute risk appears to be low based on clinical trial data

What if I miss a dose

Data on the primary outcome, the composite of all-cause mortality and HF-related hospitalization, was pooled using a random effect meta-analysis with additional subgroup analyses

In one Phase 2 trial, the drug, called elecoglipron, led patients with obesity to lose 11.2% of their weight after 36 weeks

In legal terms, this is known as failure to warn. FDA Warnings and Concerns In response to concerns about severe gastrointestinal side effects from GLP-1 drugs, the FDA updated the warning labels for drugs like Ozempic in September 2023 to include risks of intestinal blockage and ileus